LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL BIOMARKERS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 OVERVIEW OF BIOMARKER DEVELOPMENT PROCESS
EXHIBIT 4 VARIOUS ORGANIZATIONAL STRUCTURES PREVALENT AMONG BIOMARKER DISCOVERY ORGANIZATIONS (PERCENT OF TOP-20 PHARMACEUTICAL COMPANIES)
EXHIBIT 5 IMPACT OF INCREASED ADOPTION OF BIOMARKERS IN PERSONALIZED MEDICINE
EXHIBIT 6 NUMBER OF APPROVALS OF BIOMARKER-DRIVEN PERSONALIZED MEDICINE 2008-2018
EXHIBIT 7 COMPANION DIAGNOSTICS PIPELINE IN PERSONALIZED MEDICINE
EXHIBIT 8 IMPACT OF INCREASING FOCUS ON DIGITAL BIOMARKERS
EXHIBIT 9 IMPACT OF INCREASING DISCOVERY OF EPIGENETIC BIOMARKERS IN ONCOLOGY
EXHIBIT 10 IMPACT OF INCREASE IN THE NUMBER OF PIPELINE BIOMARKERS
EXHIBIT 11 IMPACT OF RISING ADOPTION OF BIOMARKERS IN DISEASE DIAGNOSTICS
EXHIBIT 12 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN BIOMARKER DISCOVERY
EXHIBIT 13 IMPACT OF HIGH COST AND TIME-CONSUMING DEVELOPMENT
EXHIBIT 14 BIOMARKER IDENTIFICATION, DEVELOPMENT, AND VALIDATION LIFECYCLE
EXHIBIT 15 GENERAL COST RANGE BY BIOMARKER CATEGORY
EXHIBIT 16 IMPACT OF HIGH NUMBER OF FALSE DISCOVERIES
EXHIBIT 17 IMPACT OF STRICT REGULATIONS AND ETHICS FOR BIOMARKER VALIDATION & QUALIFICATION
EXHIBIT 18 GLOBAL BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 19 GLOBAL BIOMARKERS MARKET SHARE BY INDICATION 2021 & 2027 (%)
EXHIBIT 20 GLOBAL BIOMARKERS MARKET SHARE BY APPLICATION 2021 & 2027 (%)
EXHIBIT 21 GLOBAL BIOMARKERS MARKET SHARE BY TYPE 2021 & 2027 (%)
EXHIBIT 22 GLOBAL BIOMARKERS MARKET SHARE BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 23 FIVE FORCES ANALYSIS 2021
EXHIBIT 24 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 25 GLOBAL BIOMARKERS MARKET BY INDICATION
EXHIBIT 26 GLOBAL BIOMARKERS MARKET BY INDICATION – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 27 GLOBAL BIOMARKERS ONCOLOGY MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 GLOBAL BIOMARKERS ONCOLOGY MARKET 2021–2027 ($ BILLION)
EXHIBIT 29 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 30 GLOBAL BIOMARKERS CARDIOLOGY MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL BIOMARKERS CARDIOLOGY MARKET 2021–2027 ($ BILLION)
EXHIBIT 32 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 33 GLOBAL BIOMARKERS NEUROLOGY MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL BIOMARKERS NEUROLOGY MARKET 2021–2027 ($ BILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 36 GLOBAL BIOMARKERS IMMUNOLOGY MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL BIOMARKERS IMMUNOLOGY MARKET 2021–2027 ($ BILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 39 GLOBAL BIOMARKERS OTHER INDICATIONS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL BIOMARKERS OTHER INDICATIONS MARKET 2021–2027 ($ BILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 42 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 43 GLOBAL BIOMARKERS MARKET BY APPLICATION
EXHIBIT 44 GLOBAL BIOMARKERS MARKET BY APPLICATION – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 45 GLOBAL BIOMARKERS MARKET BY APPLICATION – ABSOLUTE GROWTH (%)
EXHIBIT 46 TYPES OF BIOMARKERS LIKELY TESTED FOR DIAGNOSIS OF CANCER IN THE US BY 2018
EXHIBIT 47 GLOBAL BIOMARKERS DIAGNOSTICS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL BIOMARKERS DIAGNOSTICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 49 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 50 GLOBAL BIOMARKERS DRUG DISCOVERY & DEVELOPMENT MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 DRUG DISCOVERY & DEVELOPMENT PROCESSES WITH THE POTENTIAL TO BENEFIT FROM BIOMARKERS PHASE I, II, AND III
EXHIBIT 52 GLOBAL BIOMARKERS DRUG DISCOVERY & DEVELOPMENT MARKET 2021–2027 ($ BILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 54 APPLICATION AREAS OF PM
EXHIBIT 55 GLOBAL BIOMARKERS PERSONALIZED MEDICINE MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL BIOMARKERS PERSONALIZED MEDICINE MARKET 2021–2027 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 58 GLOBAL BIOMARKERS OTHER APPLICATIONS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL BIOMARKERS OTHER APPLICATIONS MARKET 2021–2027 ($ BILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 61 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 62 GLOBAL BIOMARKERS MARKET BY TYPE
EXHIBIT 63 GLOBAL BIOMARKERS MARKET BY TYPE – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 64 GLOBAL BIOMARKERS MARKET BY TYPE – ABSOLUTE GROWTH (%)
EXHIBIT 65 GLOBAL DIAGNOSTIC BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 CHROMATIN CONFORMATION: PROGNOSTIC AND PREDICTIVE BIOMARKERS WITH DIAGNOSTIC UTILITY
EXHIBIT 67 GLOBAL DIAGNOSTIC BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 69 GLOBAL MONITORING BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 70 GLOBAL MONITORING BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 71 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 72 GLOBAL PROGNOSTIC BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL PROGNOSTIC BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 74 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 75 GLOBAL PREDICTIVE BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 GLOBAL PREDICTIVE BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 77 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 78 GLOBAL SUSCEPTIBILITY BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 GLOBAL SUSCEPTIBILITY BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 80 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 81 SELECTED PHARMACODYNAMICS MARKERS IN TUMOR AND SURROGATE TISSUES
EXHIBIT 82 GLOBAL OTHER BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 83 CURRENT EMERGING SAFETY BIOMARKERS OPPORTUNITIES FOR QUALIFICATION
EXHIBIT 84 PERCENTAGE OF COMPANIES USING EMERGING SAFETY BIOMARKERS IN NONCLINICAL STUDIES
EXHIBIT 85 GLOBAL OTHER BIOMARKERS MARKET 2021–2027 ($ BILLION)
EXHIBIT 86 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 87 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 88 GLOBAL BIOMARKERS MARKET BY GEOGRAPHY
EXHIBIT 89 GLOBAL BIOMARKERS MARKET BY GEOGRAPHY – INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 90 GLOBAL BIOMARKERS MARKET BY GEOGRAPHY – ABSOLUTE GROWTH (%)
EXHIBIT 91 NORTH AMERICA BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 92 NORTH AMERICA BIOMARKERS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 93 BIOMARKERS MARKET IN NORTH AMERICA 2021–2027 ($ BILLION)
EXHIBIT 94 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 95 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 96 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 97 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 98 PERSONALIZED MEDICINES WITH SPECIFIC BIOMARKERS – TOP 20% OF FDA APPROVALS 2005-2019
EXHIBIT 99 APPROVED THERAPEUTIC MOLECULAR ENTITIES IN PERSONALIZED MEDICINE IN 2019
EXHIBIT 100 BIOMARKERS MARKET IN THE US 2021–2027 ($ BILLION)
EXHIBIT 101 CIHR PROJECTED LEVERAGE BY PARTNER TYPE FOR PERSONALIZED MEDICINE BUSINESS
EXHIBIT 102 BIOMARKERS MARKET IN CANADA 2021–2027 ($ BILLION)
EXHIBIT 103 EUROPE BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 104 EUROPE BIOMARKERS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 105 BIOMARKERS MARKET IN EUROPE 2021–2027 ($ BILLION)
EXHIBIT 106 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 107 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 108 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 109 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 110 BIOMARKERS MARKET IN GERMANY 2021–2027 ($ BILLION)
EXHIBIT 111 BIOMARKERS MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 112 BIOMARKERS MARKET IN THE UK 2021–2027 ($ BILLION)
EXHIBIT 113 BIOMARKERS MARKET IN ITALY 2021–2027 ($ BILLION)
EXHIBIT 114 BIOMARKERS MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 115 APAC BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 116 APAC BIOMARKERS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 117 BIOMARKERS MARKET IN APAC 2021–2027 ($ BILLION)
EXHIBIT 118 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 122 BIOMARKERS MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 123 BIOMARKERS MARKET IN CHINA 2021–2027 ($ BILLION)
EXHIBIT 124 BIOMARKERS MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 125 BIOMARKERS MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)
EXHIBIT 126 BIOMARKERS MARKET IN AUSTRALIA 2021–2027 ($ BILLION)
EXHIBIT 127 LATIN AMERICA BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 128 LATIN AMERICA BIOMARKERS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 129 BIOMARKERS MARKET IN LATIN AMERICA 2021–2027 ($ BILLION)
EXHIBIT 130 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 131 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 132 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 133 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 134 BIOMARKERS MARKET IN BRAZIL 2021–2027 ($ BILLION)
EXHIBIT 135 BIOMARKERS MARKET IN MEXICO 2021–2027 ($ BILLION)
EXHIBIT 136 BIOMARKERS MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 137 MIDDLE EAST & AFRICA BIOMARKERS MARKET – INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 138 MIDDLE EAST & AFRICA BIOMARKERS MARKET – KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 139 BIOMARKERS MARKET IN THE MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)
EXHIBIT 140 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 141 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 142 INCREMENTAL GROWTH BY INDICATION 2021 & 2027
EXHIBIT 143 INCREMENTAL GROWTH IN THE MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 144 BIOMARKERS MARKET IN TURKEY 2021–2027 ($ BILLION)
EXHIBIT 145 BIOMARKERS MARKET IN SOUTH AFRICA 2021–2027 ($ BILLION)
EXHIBIT 146 BIOMARKERS MARKET IN SAUDI ARABIA 2021–2027 ($ BILLION)
EXHIBIT 147 ABBOTT: TOTAL REVENUE 2018-2020 ($ BILLION)
EXHIBIT 148 ABBOTT: R&D EXPENDITURE 2018-2020 ($ BILLION)
EXHIBIT 149 BIOMÉRIEUX: R&D EXPENDITURE 2018-2020 ($ BILLION)
EXHIBIT 150 BIOMÉRIEUX: TOTAL REVENUE 2018-2020 ($ BILLION)
EXHIBIT 151 BIOHIT OYJ: TOTAL REVENUE 2018-2020 ($ BILLION)
EXHIBIT 152 BIOHIT OYJ: MARKET SHARE BY GEOGRAPHY (2020)
EXHIBIT 153 CENTOGENE: TOTAL REVENUE 2018-2020 ($ BILLION)
EXHIBIT 154 CENTOGENE: R&D EXPENDITURE 2018-2020 ($ BILLION)
EXHIBIT 155 CENTOGENE: REVENUE BY PHARMACEUTICAL SEGMENT 2018-2020 ($ BILLION)
EXHIBIT 156 CENTOGENE: MARKET SHARE BY GEOGRAPHY (2020)
EXHIBIT 157 F. HOFFMANN-LA ROCHE: TOTAL REVENUE 2018-2020 ($ BILLION)
EXHIBIT 158 GE HEALTHCARE: TOTAL REVENUE 2018-2020 ($ BILLION)
EXHIBIT 159 GE HEALTHCARE: MARKET SHARE OF HEALTHCARE SEGMENT BY GEOGRAPHY (2020)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 TYPES OF BIOMARKERS
TABLE 4 PIPELINE BIOMARKERS
TABLE 5 PORTABLE BIOSENSORS FOR BIOMARKER DETECTION FROM SALIVA
TABLE 6 SUMMARY OF PORTABLE BIOSENSORS FOR BIOMARKER DETECTION FROM SWEAT
TABLE 7 SUMMARY OF PORTABLE BIOSENSORS FOR BIOMARKER DETECTION FROM BLOOD
TABLE 8 SUMMARY OF PORTABLE BIOSENSORS FOR BIOMARKER DETECTION FROM TEARS/BREATH
TABLE 9 TIME FRAME FOR BIOMARKER DEVELOPMENT
TABLE 10 AVERAGE COST RANGES FOR PREDICTIVE BIOMARKERS AND CLINICAL TRIAL ENDPOINTS BY PHASE OF BIOMARKER DEVELOPMENT
TABLE 11 ORIGINS OF 165 FALSE POSITIVE BIOMARKERS OBTAINED
TABLE 12 PROBLEMS AT EACH STAGE OF THE BIOMARKER RESEARCH PIPELINE
TABLE 13 STEPS IN FDA BIOMARKER QUALIFICATION PROGRAM PROCEDURE
TABLE 14 BIOSENSORS FOR IMPROVED DETECTION OF DIAGNOSTIC BIOMARKERS FROM VARIOUS SOURCES
TABLE 15 METHYLATION: PROGNOSTIC AND PREDICTIVE BIOMARKERS WITH DIAGNOSTIC ABILITY
TABLE 16 HISTONE MODIFICATIONS: PROGNOSTIC & PREDICTIVE BIOMARKERS WITH DIAGNOSTIC UTILITY
TABLE 17 MICRORNA: PROGNOSTIC AND PREDICTIVE BIOMARKERS WITH DIAGNOSTIC UTILITY
TABLE 18 EXAMPLES OF SUCCESSFULLY DEVELOPED PREDICTIVE BIOMARKERS IN MODERN ONCOLOGY
TABLE 19 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 20 BIOMÉRIEUX: MAJOR PRODUCT OFFERINGS
TABLE 21 BIOHIT OYJ: MAJOR PRODUCT OFFERINGS
TABLE 22 CENTOGENE: MAJOR PRODUCT OFFERINGS
TABLE 23 CREATIVE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 24 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 25 FUJIREBIO: MAJOR PRODUCT OFFERINGS
TABLE 26 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 27 TAMIRNA: MAJOR PRODUCT OFFERINGS
TABLE 28 GLOBAL BIOMARKERS MARKET BY GEOGRAPHY 2021−2027 ($ BILLION)
TABLE 29 GLOBAL BIOMARKERS MARKET BY GEOGRAPHY 2021−2027 (%)
TABLE 30 GLOBAL BIOMARKERS MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 31 GLOBAL BIOMARKERS MARKET BY INDICATION 2021−2027 (%)
TABLE 32 GLOBAL BIOMARKERS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 33 GLOBAL BIOMARKERS MARKET BY APPLICATION 2021−2027 (%)
TABLE 34 GLOBAL BIOMARKERS MARKET BY TYPE 2021−2027 ($ BILLION)
TABLE 35 GLOBAL BIOMARKERS MARKET BY TYPE 2021−2027 (%)
TABLE 36 NORTH AMERICA BIOMARKERS MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 37 NORTH AMERICA BIOMARKERS MARKET BY INDICATION 2021−2027 (%)
TABLE 38 NORTH AMERICA BIOMARKERS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 39 NORTH AMERICA BIOMARKERS MARKET BY APPLICATION 2021−2027 (%)
TABLE 40 NORTH AMERICA BIOMARKERS MARKET BY TYPE 2021−2027 ($ BILLION)
TABLE 41 NORTH AMERICA BIOMARKERS MARKET BY TYPE 2021−2027 (%)
TABLE 42 EUROPE BIOMARKERS MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 43 EUROPE BIOMARKERS MARKET BY INDICATION 2021−2027 (%)
TABLE 44 EUROPE BIOMARKERS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 45 EUROPE BIOMARKERS MARKET BY APPLICATION 2021−2027 (%)
TABLE 46 EUROPE BIOMARKERS MARKET BY TYPE 2021−2027 ($ BILLION)
TABLE 47 EUROPE BIOMARKERS MARKET BY TYPE 2021−2027 (%)
TABLE 48 APAC BIOMARKERS MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 49 APAC BIOMARKERS MARKET BY INDICATION 2021−2027 (%)
TABLE 50 APAC BIOMARKERS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 51 APAC BIOMARKERS MARKET BY APPLICATION 2021−2027 (%)
TABLE 52 APAC BIOMARKERS MARKET BY TYPE 2021−2027 ($ BILLION)
TABLE 53 APAC BIOMARKERS MARKET BY TYPE 2021−2027 (%)
TABLE 54 LATIN AMERICA BIOMARKERS MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 55 LATIN AMERICA BIOMARKERS MARKET BY INDICATION 2021−2027 (%)
TABLE 56 LATIN AMERICA BIOMARKERS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 57 LATIN AMERICA BIOMARKERS MARKET BY APPLICATION 2021−2027 (%)
TABLE 58 LATIN AMERICA BIOMARKERS MARKET BY TYPE 2021−2027 ($ BILLION)
TABLE 59 LATIN AMERICA BIOMARKERS MARKET BY TYPE 2021−2027 (%)
TABLE 60 MIDDLE EAST & AFRICA BIOMARKERS MARKET BY INDICATION 2021−2027 ($ BILLION)
TABLE 61 MIDDLE EAST & AFRICA BIOMARKERS MARKET BY INDICATION 2021−2027 (%)
TABLE 62 MIDDLE EAST & AFRICA BIOMARKERS MARKET BY APPLICATION 2021−2027 ($ BILLION)
TABLE 63 MIDDLE EAST & AFRICA BIOMARKERS MARKET BY APPLICATION 2021−2027 (%)
TABLE 64 MIDDLE EAST & AFRICA BIOMARKERS MARKET BY TYPE 2021−2027 ($ BILLION)
TABLE 65 MIDDLE EAST & AFRICA BIOMARKERS MARKET BY TYPE 2021−2027 (%)